Travis Osterman Archives
Targeted cancer drug during pregnancy
Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.
Osterman plays key role in major oncology EHR initiative
Feb. 3, 2022—Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.
VUMC’s Osterman awarded Microsoft Investigator Fellowship
Nov. 7, 2019—Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.
